SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) without considering cardiovascular and kidney risks, according to a BMJ ...

Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

In 2025, Släcka introduces a functional beverage designed to combat mid-afternoon cravings by offering a healthier ...

GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...

Given GLP-1 receptor agonists' established effects on weight, Poizeau and colleagues investigated whether the blockbuster ...

More evidence shows a risk between GLP-1 drugs and vision risks. A study in JAMA Network Open adds more evidence linking ...